Article Versions Notes

Stanneart J, Nunez KG, Sandow T, Gimenez J, Fort D, Hibino M, Cohen AJ, Thevenot PT. Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma. Cancers. 2024; 16(1):212. https://doi.org/10.3390/cancers16010212

Stanneart, Jordin, Kelley G. Nunez, Tyler Sandow, Juan Gimenez, Daniel Fort, Mina Hibino, Ari J. Cohen, and Paul T. Thevenot. 2024. "Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma" Cancers 16, no. 1: 212. https://doi.org/10.3390/cancers16010212

Stanneart, J., Nunez, K. G., Sandow, T., Gimenez, J., Fort, D., Hibino, M., Cohen, A. J., & Thevenot, P. T. (2024). Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma. Cancers, 16(1), 212. https://doi.org/10.3390/cancers16010212